2014
DOI: 10.1111/vde.12107
|View full text |Cite
|
Sign up to set email alerts
|

Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)‐4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs

Abstract: The CADESI-4 is simpler to use and quicker to administer than its previous version. The ICADA recommends the CADESI-4 instead of the CADESI-3 to score skin lesions of AD in dogs enrolled in clinical trials.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
213
0
4

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 157 publications
(221 citation statements)
references
References 13 publications
4
213
0
4
Order By: Relevance
“…Even though the QoL questionnaire has been validated and is applicable to all dermatological conditions, the pre‐question and interview were not validated. The CADESI‐04 score has been validated, but only for dogs with atopic dermatitis . Nevertheless, it was considered the best available option for this study.…”
Section: Discussionmentioning
confidence: 99%
“…Even though the QoL questionnaire has been validated and is applicable to all dermatological conditions, the pre‐question and interview were not validated. The CADESI‐04 score has been validated, but only for dogs with atopic dermatitis . Nevertheless, it was considered the best available option for this study.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, comparison of the median pruritus scores before and after treatment is preferred to using the number of dogs showing a 50% improvement as a primary outcome measure [21]. Apart from the VAS, there are severity scales to grade skin lesions in clinical trials, such as CADESI-04 [18]. However, these scales are more useful in long term studies [10].…”
Section: Discussionmentioning
confidence: 99%
“…This period was at least 14 days for topical glucocorticoids, oral glucocorticoids, and antihistamines, and at least 4 weeks for long-acting corticosteroids [1821]. During the withdrawal period, dogs were treated with 3% chlorhexidine shampoo (Douxo; Sogeval Laboratories, France; 1–2 times weekly) to prevent development of secondary infections.…”
Section: Methodsmentioning
confidence: 99%
“…Since 1997, objective lesion scores for canine atopic dermatitis (AD) have been developed and evaluated . The International Task Force on Canine AD [now the International Committee on Allergic Diseases of Animals (ICADA)] established the fourth version of the Canine Atopic Dermatitis Extent and Severity Index (CADESI‐4) in 2014 . The CADESI‐4 assesses erythema, lichenification, and alopecia/excoriations over 20 body regions on a 0–3 severity scale.…”
Section: Introductionmentioning
confidence: 99%